Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.001?!?! .001!!!!!??????!!!!
You goats are an absolute embarrassment. I’m disgusted. I have shares to buy and you can’t move this thing more than a tenth of a cent? I want answers. Be at Cave #107 at 6am sharp tomorrow. Results better start happening soon here or I’m gonna cancel the shipments of hair removal lip cream. Drop the price like you’ve bragged that you can or you’ll be smooching stubble by this weekend.
Intelligent. Thats rich. Hear/Here
People are getting the BuyOut price and share price confused.
They will be very different till the BuyOut happens in 22 months
She/Him has been one of The "Dollar-Land" hypesters for a decade and frankly, He/She has nothing else to offer !!!!!!!!!!!!
IB_🤴🏻
Expectations seem to be falling, drastically !!!!!!!!!!!!!!!!!!!!!!!!!!
$0.31 next year ............ Why is "Dollar-Land" not the prediction ???????????????????
IB_🤴🏻
Please get a new line You say the same moronic bs in every post How bout an intelligent post at least once in a while why are you hear? Why are you hear? Try something new please!!!
You have spent 10 years here and you have no idea why. Aren't you curious?
When you were assigned to the role, did you think you would have to be here for 10 years and have no clue why?
Good luck It hasn’t been in 10 years What makes you think it will And only 30 cents What happened to all the many dollars prediction lol
in exactly 1 year I plan to retire...4/30/2025
Better be above 30 cents by then
Ok if you say so ?
i USE AN iPAD AFTER work and the Emogies are all visible to me
You are missing a Font. Emojis font.
No prob, didn’t notice, lol
OMG - Yes you did NAS - good job...
ON MY LAP TOP EMOGIS LOOK LIKE SQUARES
Sorry Sharkey if I gave you a goat.
Hglis did I fix it ??
Aren't we ALL on the same side ???????????????
IB_🕍
Hi NAS, why the goat for Sharkey? lol
Sharkey is on our side
15 days is up, Elite is due for another inspection, hopefully we get an update on the new building.
$10 BILLION combined IMS markets.:
5% = $$ 500,000,000 P/E Ratio 6 -> $3 P/E Ratio 8-> $4 per share
7.5% = $$$$750,000,000 P/E Ratio 6 -> $4.5 P/E Ratio 8-> $6 per share
10% = $$$$$$1,000,000,000 P/E Ratio 6-> $6 P/E Ratio 8 -> $10 per share
Your job still sucks. Aren't you curious at all why you are here?
How much of the $10b market does Elite currently own?
$10 bILLION combined IMS markets.:
5% = $$ 500,000,000
7.5% = $$$$750,000,000
10% = $$$$$$1,000,000,000
BULLISH ELTP
FDA Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Catalyst check off:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
__14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then Launch
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
X 18. PE ratio below 8
__19. Generate revenues over $20 million/quarter
__20. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__21. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__22. Legislation to make manufacturing generic drugs more profitable
__23. European distribution - Dexcel partnership approval by Israeli Health
__24. Full ownership of Adderall IR $ 335 Million
__25. Full ownership of Adderall XR $ 1.56 Billion
__26. Generic Concerta- $1.2 BILLION FDA submission
__27. $100 million in yearly revenue
__28. Generic Vyvanse Approval and Launch
__29. $200 million in yearly revenue
__30. Deep pocket partner for SequestOx
__31. Patented Unique ADF (w/o naltrexone)-- NDA
__32. Mikah ANDA (s)
__33. Undisclosed ANDAs/NDAs
__34. DollarLand PPS
__35. Uplist to the NASDAQ Exchange
__36. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__37. Vegas Baby !!!!!!!
you could do it if you bring it down yourself and bring it back up at end of day
Hard to buy another 5 million shares if these minimum wagers can’t really drop the price like they pretended they could. It’s really disappointing but maybe this is why they are relegated to keyboard warriors on a chat board.
Is this Project Hessdallen for Bigfoot sightings~? Imagine if we grabbed the Bigfoot market for OxyContin.
That's a lot of pain.
He would also put a huge demand on the OxyCotton market. That's a lot of thread man~!
$ELTP baby~!
That works too - keeps them warm in the winter
Some time you see sheep, when the grass is green, lol
I though you were playing the on location stream - expected goats not deers
Project Hessdallen is up and running again, if your bored to tears
better than the news
THX, I needed a laugh,
in these most trying times.
Ya know, I had the hardest time spelling contin, or saying it, for years.
sounds like cotton
Egyptian cotton
Cotton polyester blend
cotton tee shirts
cotton socks
everyday cotton cotton cotton , lol
Let's hope the FDA picks Contin!
That information is in the table at the bottom of the board....I"m thinking your just asking to get it posted and know it yourself? If not, wow, pay attention to the details of the OTC you invest in! The first two (filed earliest) are the ones that have passed their PDUFA date. I do not think they will necessarily be approved before the end of June. I think the FDA came back with questions and Nasrat had to look at everything going on and decide if pulling someone away from their day job or spending any more money to satisfy questions from FDA on po-dunk products was worth it. Other items Elite has going on that maybe more important includes:
- answering any questions related to Oxy and Vyvanse
- setting up new packaging facilities
- keep research/progress moving on new $billion dollar market products
Dopamine Agonist 12 M Filed with FDA - 22 Dec 2022 ---------- ----------
Antimetabolite 42 M Filed with FDA - 20 Apr 2023 ---------- ----------
Generic OxyContin 720 M Filed with FDA - 17 Aug 2023 ---------- ----------
Generic Vyvanse 5.1 B Filed with FDA - 21 Dec 2023 14 ----------
Want to add a "thank you!" the people/peoples that keep the table of products up to date. It is a very helpful resource that gives new and existing investors a quick overview of current and future potential.
Sorry, that's above my pay grade , lol
Thanks Sharkey.
Out of the 4 ANDA's at the FDA - do you happen to know how many (and which ones) have passed the PDUFA date and are likely to be approved before end of June?
The clock is ticking
https://finance.yahoo.com/news/elite-pharmaceuticals-files-anda-us-100000129.html
7 months ago they filed for generic Oxi.
lets see if Tentative Approval goes threw early.
can;t hurt, the FDA knows what's on the table
and Elite has been working on this Contin for a long time
Yes, and another thing, I've looked and looked on their product page and not a peep about generic Vyvanse, though they do make it.
See, they don't have to update products if they don't want to
Holly moly.
Lannett became private. Sc@@ed their investors.
Sour end.
Good we departed from them.
Could this be a roadmap for Mikah er I mean Elite??
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Lot number and expiration date is imprinted in the unvarnished area.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e677690f-790f-4626-ad78-097cdb6ea540
Go to the left, look at package fotos, more recent lables, 9/22
With the unvarnished area, they must have a problem with varnish on these lables,
On the bottom bottle you can see the NDC, National Drug Code
64850-505-1
Google
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e677690f-790f-4626-ad78-097cdb6ea540
That number now follows Elite every where it goes.
https://fda.report/NDC/64850-505#64850-505-30
Amd of course it comes with lables
https://www.google.com/search?client=safari&sca_esv=b5f6560b0f349675&sca_upv=1&channel=ipad_bm&q=64850+505+label&tbm=isch&source=univ&fir=Oj8c4VoAR1Q6iM%252CV5WPVEunpkY0IM%252C_%253BzYtUT6ZUjemzeM%252CV5WPVEunpkY0IM%252C_%253Bt336OKhjd-aTwM%252CTsZ5aYBvgk80jM%252C_%253B_rCTeaTXSbyBoM%252CosbGmwyEsmbbvM%252C_%253ByuHd8q8uBBK9LM%252CDoH2qoHNz3e3kM%252C_%253BkoQDW85AmzfFqM%252Cdz_sly2gfejK4M%252C_%253BCSirtpGSHlIsXM%252Cazc3cK7BUEejwM%252C_%253BfHIP5vw3cW__zM%252CPr44zVVVTpUcsM%252C_%253BJRQcI3iLdVY16M%252CrBjSSccL3TBlaM%252C_%253BPKSPSjkw0SRa-M%252CvBddztKW4lLQHM%252C_&usg=AI4_-kSyXVGq4VrnWney0KM_ickgiJ4TeQ&biw=695&bih=964&dpr=2
Followers
|
1026
|
Posters
|
|
Posts (Today)
|
90
|
Posts (Total)
|
410967
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite Prasco Dexcel |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 47 M | On Market | 5 | Elite |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |